R

Avidity Biosciences
D

RNA

72.330
USD
-0.05
(-0.07%)
مغلق
حجم التداول
29,738
الربح لكل سهم
-4
العائد الربحي
-
P/E
-17
حجم السوق
10,898,376,419
أصول ذات صلة المقالات

العنوان: Avidity Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.